The Dynamics of Human Atrial Fibrillation
- Conditions
- Atrial FibrillationAtrial Tachyarrhythmia
- Registration Number
- NCT01008722
- Lead Sponsor
- University of California, San Diego
- Brief Summary
The study is conducted in patients with atrial fibrillation undergoing clinically prescribed ablation. The study hypothesis is that ablation at specific sites that are identified to 'drive' the atrial fibrillation may improve the success of the ablation procedure.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 98
- Subjects will be patients undergoing electrophysiology study and ablation for paroxysmal or persistent atrial fibrillation (AF) after having failed >or= 1 anti-arrhythmic drug.
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival Free of Atrial Fibrillation 6 -12 months Using data from cardiac implanted devices when possible, with recurrence defined as 1% recurrence, or data from intermittent 24-72 hour ambulatory ECGs, with recurrence defined as \>30 seconds.
- Secondary Outcome Measures
Name Time Method Termination or Slowing of Atrial Fibrillation During Ablation acute Using data from electrophysiological study, to determine termination of AF into sinus rhythm or organized atrial tachycardia. or slowing by 10% in cycle length measured on the coronary sinus.
Trial Locations
- Locations (2)
University of California, San Diego
🇺🇸La Jolla, California, United States
VA San Diego Medical Center
🇺🇸San Diego, California, United States